flag flag  

A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: Results from the EuroSIDA study

Description : The risk of clinical progression for human immunodeficiency virus (HIV)-infected persons receiving treatment with highly active antiretroviral therapy (HAART) is poorly defined. From an inception cohort of 8457 HIV-infected persons, 2027 patients who started HAART during prospective follow-up were e...
Language(s) : Undetermined
Subject(s) : HIV-INFECTED PATIENTS, HUMAN-IMMUNODEFICIENCY-VIRUS, CD4 CELL COUNT, PNEUMOCYSTIS-CARINII-PNEUMONIA, LONG-TERM SURVIVAL, RNA LEVELS, LYMPHOCYTE COUNTS, VIROLOGICAL FAILURE, PRIMARY PROPHYLAXIS, STAGING SYSTEM
Publisher(s) : UNIV CHICAGO PRESS
Contributor(s) :
Source(s) :
Publication Date(s) : 2002-01-15